Intravenous thrombolysis is the only approved systemic reperfusion treatment for patients
with acute ischaemic stroke. These European Stroke Organisation (ESO) guidelines provide …

Intracranial hemorrhage is one of the most feared complications following brain infarct.
Ischemic tissues have a natural tendency to bleed. Moreover, the first recanalization trials …

Intravenous thrombolysis (IVT) represents the only systemic reperfusion therapy able to
reverse neurological deficit in patients with acute ischemic stroke (AIS). Despite its …

Aim Our study aimed to explore the effectiveness and safety of intravenous t‐PA compared
with dual antiplatelet therapy (DAPT) and aspirin alone for minor stroke with National …

Objective: This study assessed the characteristics of intravenous thrombolysis (IVT) with
respect to early neurological deterioration (END) and functional outcome in mild ischemic …

Background and purpose Better understanding the incidence, predictors and mechanisms of
early neurological deterioration (END) following intravenous thrombolysis (IVT) for acute …

Background: The benefit of distinguishing between disabling versus nondisabling deficit in
mild acute ischemic stroke due to endovascular thrombectomy-targetable vessel occlusion …

Background and purpose The best reperfusion treatment for patients with mild acute
ischaemic stroke harbouring proximal anterior circulation large vessel occlusion (LVO) is …

Background: Minor ischemic stroke, defined as National Institute of Health Stroke Scale
score of 0–5 on admission, represents half of all acute ischemic strokes. The role of …

Cerebral vessel recanalization therapy, either intravenous thrombolysis or mechanical
thrombectomy, is the main treatment that can significantly improve clinical outcomes after …